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Sequence-dependent electrophoresis (SDE) fingerprinting techniques such as denaturing gradient gel electrophoresis (DGGE)
have become commonplace in the field of molecular microbial ecology. The success of the SDE technology lays in the fact that
it allows visualization of the predominant members of complex microbial ecosystems independent of their culturability and
without prior knowledge on the complexity and diversity of the ecosystem. Mainly using the prokaryotic 16S rRNA gene as PCR
amplification target, SDE-based community fingerprinting turned into one of the leading molecular tools to unravel the diversity
and population dynamics of human intestinal microbiota. The first part of this review covers the methodological concept of SDE
fingerprinting and the technical hurdles for analyzing intestinal samples. Subsequently, the current state-of-the-art of DGGE and
related techniques to analyze human intestinal microbiota from healthy individuals and from patients with intestinal disorders is
surveyed. In addition, the applicability of SDE analysis to monitor intestinal population changes upon nutritional or therapeutic
interventions is critically evaluated.
Copyright © 2008 Geert Huys et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The mammalian intestinal tract comprises a highly complex
population of microorganisms reaching up to 1014 bacteria
in the large intestine [1]. Starting oﬀ as a sterile system
at birth, microbial colonization of the intestine develops in
a successive manner in which bacteria predominate along
with lower numbers of archae, yeasts, filamentous fungi,
parasites, and viruses [2, 3]. Following initial domination by
facultative anaerobes, the gut microbiota becomes gradually
inhabited by obligate anaerobes which will remain its major
constituents during adult life [4–7]. Triggered by the growing
number of 16S ribosomal RNA (rRNA)-based approaches,
insights in the evolutionary diversity of the human adult
gut flora has changed drastically in recent years. Based on a
delineation level of 98% 16S rRNA gene sequence similarity,
current estimates indicate that the human gastrointestinal
tract encompasses more than 1000 bacterial phylogenetic
types, also referred to as phylotypes or “molecular species”
[8–10]. These taxonomic inventory studies have revealed
that the gut microbiota in adults is largely dominated
by members of only two bacterial phyla, that is, the
Bacteroidetes and the Firmicutes, and one member of the
archaea, Methanobrevibacter smithii. Through a complex
network of mutualistic interactions, the gut microbiota has
a profound impact on the host’s health by acting as a
barrier against pathogens, contributing to the degradation of
food components, stimulating the host immune system, and
producing a series of essential vitamins, enzymes, and short-
chain fatty acids [11–14].
Until a decade ago, knowledge on the taxonomic com-
position and metabolic activity of the intestinal tract micro-
biota was mainly based on the use of culture-dependent
techniques. Triggered by the growing awareness that only
a fraction of the gut microbiota is culturable under lab-
oratory conditions, various culture-independent methods
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have been evaluated in intestinal microbial ecology [15–
19]. Depending on the scientific rationale and technical
design of the study, molecular approaches for assessing
diversity and dynamics of intestinal microbiota include
population fingerprinting [this review], clone libraries [20–
23], dot blot hybridization [24, 25], fluorescent in situ
hybridization (FISH) [8, 26–29], real-time PCR [30–33],
DNA microarrays [34–36], and metagenomics [9, 37–
39].
In contrast to several of the aforementioned techniques
that specifically target one or more autochthonous members
of intestinal tract or that require analysis of large and
complex datasets, population fingerprinting is a universal
concept that allows one to characterize and monitor intesti-
nal microbiota without preexisting knowledge of its structure
or composition. The most commonly used fingerprinting
techniques in the field of intestinal microbiology are based on
the sequence-dependent electrophoresis (SDE) principle and
include denaturing gradient gel electrophoresis (DGGE),
temperature gradient gel electrophoresis (TGGE), and tem-
poral temperature gradient gel electrophoresis (TTGE).
In contrast to conventional gel electrophoresis based on
fragment size, the SDE principle relies on the sequence-
dependent electrophoretic separation of a mixture of equally
sized PCR products in a polyacrylamide gel containing a
linear gradient of chemical denaturants (DGGE) or a linear
temperature gradient (TGGE and TTGE). This way, separa-
tion is achieved by the gradually decreasing electrophoretic
mobility of partially melted, double-stranded amplicons in
the denaturing gradient. PCR fragments equal in length but
with diﬀerent sequences have a diﬀerent melting behavior
and will stop migrating at diﬀerent positions along the
gel, eventually producing a banding pattern or fingerprint.
To a lesser extent, also single-strand conformation poly-
morphism (SSCP) [40] and terminal-restriction fragment
length polymorphism (T-RFLP) [41] analysis have been
applied in microbial community profiling. Likewise SDE
methods, both these methods rely on PCR amplification
of specific target sequences followed by electrophoretic
separation of amplicons. Whereas this separation is based
on sequence-specific melting behavior of amplicons in
SDE analysis, the taxonomic resolution of SSCP and T-
RFLP is determined by the secondary structure of ssDNA
or by the distribution of endonuclease restriction sites,
respectively. The principle of SSCP analysis is essentially
based on the sequence-dependent diﬀerential intramolecular
folding of ssDNA which alters the migration speed of the
molecules [42]. The ssDNA fragments originating from PCR
amplicons are separated using uniform, low temperature,
nondenaturing electrophoresis to maintain the secondary
structure of the single-stranded fragments. T-RFLP anal-
ysis, on the other hand, is based on a size-dependent
electrophoretic separation of digested fluorescently end-
labeled PCR products. Upon electrophoresis using either
gel- or capillary-based systems, only the “terminal” end-
labeled restriction fragments are detected. Although less
commonly used than DGGE and related techniques, SSCP
[43] and, especially, T-RFLP [44–48] have been applied to
study the diversity and dynamics of intestinal microbiota.
This review will specifically focus on the use of SDE
techniques, and DGGE in particular, in the field of intestinal
microbiology.
Since their introduction in microbial ecology in the
early 1990s [49], SDE fingerprinting techniques have been
employed to analyze microbial communities in a wide range
of environments including aquatic sites [50–52], soil [53],
fermented foods [54, 55], and the human intestinal tract [this
review]. The value of SDE-based fingerprinting methods
in intestinal microbiology lays in the fact that they allow
pattern-based visualization of the predominant bacterial
groups including poorly culturable and currently uncultured
bacteria that are considered to represent up to 50–90% of the
intestinal microbiota.
This review will deal with all diﬀerent aspects of
SDE methodology including its possibilities and limitations
in terms of reproducibility, sensitivity, and data analysis.
Through discussion of selected studies that have contributed
to the field, an overview will be presented of SDE-based
research approaches to study human intestinal ecosystems
in relation to the microbial ecology of healthy and disease-
aﬀected populations. The scope of this review excludes SDE
applications dealing with the human upper gastrointestinal
tract or with animal intestinal ecosystems.
2. METHODOLOGY
2.1. Principle
The principle of SDE techniques relies on the electrophoretic
separation of PCR amplicons with equal length in a
sequence-specific manner in a polyacrylamide matrix con-
taining a defined denaturing gradient of urea and formamide
(DGGE) or temperature gradient (TGGE and TTGE). The
temperature gradient in TGGE is created along the length of
the gel, whereas in TTGE a temporal temperature gradient
is gradually formed during the electrophoresis run. The
electrophoretic mobility of double-stranded amplicons in a
gel matrix with an increasing denaturing gradient is retarded
at a given chemical denaturant concentration or temperature
that causes (partial) melting of the sequence region with
lowest melting temperature (Tm). The physical denaturation
of the dsDNA fragment is thus largely determined by its
nucleotide sequence and %G+C content and proceeds in
discrete portions of the fragment or the so-called melting
domains. These domains interfere with the helical structure
of the DNA molecule and will eventually halt further
migration. Amplicons that are diﬀerent at the sequence level
are likely to display a diﬀerent melting behavior and will,
therefore, stop migrating at diﬀerent positions along the
linear gradient of the gel, which upon visualization will result
in band profiles representing the sequence diversity of the
amplicon mixture.
In practice, SDE-based community profiling comprises
four steps: (i) extraction of total community DNA from
the sample; (ii) PCR-controlled amplification using spe-
cific oligonucleotide primers; (iii) sequence-dependent elec-
trophoretic separation of the amplicons using either DGGE,
TGGE or TTGE; and (iv) fingerprint processing and analysis.
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2.2. Sampling and total DNA extraction
2.2.1. Sample collection and processing
The endogenous microbiota diﬀers along the length of
the intestinal tract [56]. In addition to the longitudinal
diversity gradient, also a cross-sectional diﬀerentiation of the
microbial population has been observed in the lumen, the
mucosa, and the epithelium surface [56, 57]. Mainly due
to sampling diﬃculties, the taxonomic composition of these
microhabitats in the intestinal tract is poorly documented.
Because of this spatial distribution, microbiological data
obtained from a subsample of the gut cannot always be
extrapolated to the global composition of the entire intestinal
microbiota. Most often, fecal samples are used to study the
intestinal microbiota because they are the most accessible
type of specimen that can be collected from this envi-
ronment. In specific clinical cases, also luminal endoscopy
samples, mucus, biopsies, and stoma liquid can be analyzed.
In most studies, immediate processing of samples is not
feasible due to the need for transportation and/or (long-
term) storage of the specimen. It has been shown that
storage of stool samples at room temperature and even at
4◦C showed a substantial reduction in bacterial diversity
and the degradation of bacterial DNA after 8 hours [58].
Therefore, it is generally recommended that colon samples
should be (deep-)frozen immediately upon collection and
stored at maximally −20◦C and preferably at −70◦C, until
further processing. However, it should be kept in mind
that repeated freezing and thawing of samples can have
negative eﬀects on bacterial viability and recovery rates [59–
61]. Although poorly documented, the impact of subsequent
sample manipulations on DNA extraction and the yield and
quality of the resulting DNA probably is less dramatic [62].
2.2.2. Extraction of community DNA
An eﬃcient, reproducible, and high-yield method for total
DNA extraction is indispensable in order to obtain a
representative view of the actual microbial composition of
an intestinal sample. The most crucial step in any DNA
extraction procedure is cell lysis. A series of methods
including commercial kits and inhouse laboratory proto-
cols have been described and evaluated for the extraction
of total bacterial DNA or RNA from intestinal samples
making use of chemical, mechanical (e.g., beads), and/or
enzymatic lysis [63–67]. Because not all members of the
intestinal microbiota display the same sensitivity to the lysis
conditions of a given procedure, it is extremely diﬃcult,
if not impossible, to extract DNA from all constituting
species with the same eﬃciency. Furthermore, the DNA
isolation procedure should also be able to remove potential
PCR inhibitors that may be present in fecal samples such
as phenols, bile salts, degradation products of hemoglobin,
and complex polysaccharides of plant origin. The selection
criteria usually applied to evaluate the eﬃcacy of a DNA
extraction method include electrophoretic verification of
DNA integrity, determination of DNA yield and quality
using spectrophotometric analysis and quality control of
the obtained SDE profile [64–66]. In addition, the lysis
eﬃciency of diﬀerent DNA extraction protocols can be
compared based on the complexity and band intensity
of SDE community fingerprints. Upon extraction, DNA
solutions are generally stored at −20◦C. The influence of
storage conditions and duration of storage on the integrity
and quality of total DNA extracts from intestinal samples has
not been studied in great detail.
Depending on the type of (clinical) application, high-
quality community DNA may need to be obtained from a
range of diﬀerent sample types such as digesta, mucosal,
and fecal samples. For this reason, the DNA extraction
technique should be carefully selected and possibly further
evaluated or optimized with particular attention for the
type and number of specimens [66]. In this respect, it may
be less appropriate to use commercial DNA extraction kits
given the limited possibilities to optimize the procedure,
for example, by changing concentrations or composition of
extraction reagents. On the other hand, commercial kits can
considerably reduce the hands on time compared to more
complex inhouse protocols. In Table 1, technical details are
given for a number of frequently used total DNA extraction
procedures that have been used in SDE-based profiling of
human intestinal microbial communities [6, 21, 24, 32, 33,
43, 63–66, 68–109].
2.3. Community PCR
Following DNA extraction and purification, multiple primer
sets with diﬀerent taxonomic coverage can be applied for
community PCR amplification. The use of universal PCR
primers allows any microbial community to be analyzed,
although in ecosystems with a high diversity like the
intestinal tract only the (pre)dominant constituents will in
eﬀect generate a visible band in SDE. In order to focus on a
specific subpopulation within the total community, group-
specific PCR primers can be used which allow detection of
bacterial taxa that are less prevalent in the intestinal tract.
Traditionally, universal and specific community PCR primers
for SDE applications are designed using the 16S rRNA gene
as a target molecule. This preference stems from the fact that
the SSU rRNA gene has a mosaic structure composed of both
invariant, relatively conserved, and highly variable regions (V
regions). In SDE-based population fingerprinting, primers
are used that anneal to conserved sequence parts of the
gene in order to cover one up to three hypervariable
regions. In Table 2, a selection is presented of universal
and specific primer sets that have been used in SDE-based
profiling of human intestinal microbial communities [6,
30, 64, 65, 69, 71–74, 76, 77, 79–82, 84–86, 88, 90, 91,
94–96, 98, 99, 101, 102, 105–130]. Taking the rumen as
model system of complex microbial community, Yu and
Morrison [131] systematically compared a set of DGGE
profiles obtained with universal primers targeting diﬀerent
V regions. Based on sequence variability and temperature
heterogeneity of the lowest Tm domain of the V region
and on the number, resolution, and relative intensity of the
bands in the resulting DGGE profile, the V3 region was most
preferred for analyzing intestinal microbiomes. In addition,
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Table 1: DNA extraction procedures used in SDE-based profiling of human intestinal microbial communities.
Description or
reference
Sample type Cell lysis (reagents or principle) DNA extraction Application(s)
Selected
reference(s)
FastDNA kit
(Bio101
Carlsbad, Calif,
USA)a FastDNA
SPIN kit
(Qbiogene,
Carlsbad, Calif,
USA)a
Feces; mucosa
biopsies
Chemical (guanidium salts and
detergents) and mechanical
(bead beating using garnet mix)
Silica-based
binding matrix
(and spin filters)a
DGGE; SSCP;
real-time PCR;
cloning; sequencing
[43, 63, 68–76]
QIAampDNA
Stool Mini Kit
(Qiagen,
Valencia, Calif,
USA)
Feces; mucosa
biopsies
Chemical (guanidium salts and
detergents)
Silica-gel
membrane spin
columns
DGGE; TGGE;
real-time PCR;
cloning; sequencing
[63, 77–86]
Modified
protocol of [87]
Feces
Enzymatic (lysozyme and
mutanolysin) and
chemical-enzymatic (SDS and
proteinase K)
Phenol-
chloroform-
isoamylalcohol
and chloroform
DGGE; sequencing [88]
Modified
protocol of [89]
Feces
Enzymatic (lysozyme and
mutanolysin) and chemical
(guanidiumthiocyanate-EDTA-
sarkosyl)
Chloroform-
isoamylalcohol
DGGE; real-time
PCR
[64, 90]
[24]
Feces; mucosa
biopsies
Mechanical (bead beating) TTGE [91–94]
[95]
Feces; cecal
fluids; mucosa
biopsies
Mechanical (bead beating in acid
phenol)
Phenol-
chloroform and
chloroform
DGGE; TGGE;
cloning; sequencing
[6, 65, 66, 96–
102]
[32] Feces
Mechanical-chemical (bead
beating in buﬀer-saturated
phenol and SDS)
Phenol-
chloroform
Group-specific PCR;
real-time PCR
[33]
[103] Feces
Chemical
(guanidiumthiocyanate and
sarkosyl) and mechanical (bead
beating)
Polyvinyl-
polypyrrolidone
TTGE; cloning;
sequencing
[21, 104–109]b
a
FastDNA kit (Bio101) and FastDNA SPIN Kit (Qbiogene) only diﬀer in the use of spin filters during the silica-DNA purification.
bThe authors of [106–108] reported a modified protocol of [103] in which also phenol and chloroform-isoamylalcohol were applied in the extraction
procedure.
the authors recommended to use the V3–V5 or V6–V8
regions if a longer amplicon is preferred. Next to the SSU
rRNA gene, also its rRNA counterpart can be coextracted
and used as PCR template in SDE analyses of intestinal
ecosystems when preceded by reverse transcription [70, 71,
75, 93, 95]. In this way, SDE profiles are generated that
represent the (pre)dominant metabolically active bacteria
based on the assumption that the cells of these organisms
generally have a much higher ribosomal RNA content and
rRNA/DNA ratio compared to resting cells.
An additional 40-nucleotide GC rich sequence, the so-
called GC-clamp, is usually attached to the 5′ end of one
or both of the PCR primers and participates in the PCR
reaction. This way, the GC-tail generated at the end of the
amplicon will prevent complete denaturation of the product
and is necessary to obtain a stable melting behavior of the
fragments during electrophoresis [49, 132, 133]. GC-clamps
can vary in sequence, length, and location [100, 134–136],
and their design needs to be based on the target sequence
and the primers used. Mutation analysis data have shown
that GC-clamps have the strongest eﬀect on the melting
properties of short fragments (<300 bp) and that this eﬀect
may be drastically reduced for large fragments (>400 bp)
[136]. Also, it has been demonstrated that a GC-clamp length
of 60 bpmay be eﬃcient for detection of fragments with a Tm
value close to 80◦C whereas fragments with Tm > 80◦C may
require longer GC-clamps in combination with naturally
occurring high-melting (thus GC-rich) domains [136].
2.4. Sequence-dependent electrophoresis
2.4.1. Electrophoresis conditions
Essentially, a DGGE system consists of a heated buﬀer tank
operated under strict control of temperature and stable
buﬀer circulation. Several systems are currently available,
of which DCode (Bio-Rad Laboratories; http://www.bio-rad
.com/), INGENYphorU (Ingeny; http://www.ingeny.com/),
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Table 2: Universal and group-specific PCR primers used in SDE-based profiling of human intestinal microbial communities.
Target group(s)
Primer
designation
Sequence (5′-3′)a Target region Selected reference(s)
Domain level
Bacteria
HDA1b ACTCCTACGGGAGGCAGCAGT V2-V3-16S rDNA [30, 76, 102, 110–114]
HDA2b GTATTACCGCGGCTGCTGGCAC
F357 CCTACGGGAGGCAGCAG V3-16S rDNA [64, 72, 73, 77, 79, 115–117]
518R ATTACCGCGGCTGCTGG
339Fc CTCCTACGGGAGGCAGCAG V3-V4-16S rDNA [94, 106, 107]
788R GGACTACCAGGGTATCTAA
U968-F AACGCGAAGAACCTTAC V6–V8-16S rDNA [6, 64, 65, 69, 71, 79, 80, 82, 84, 85,
91, 95, 96, 101, 105, 109, 117–123]L1401-R CGGTGTGTACAAGACCC
Genus (group) level
Bacteroides
FD1 AGAGTTTGATCCTGGCTCAG 16S rDNA [124]
RbacPre TCACCGTTGCCGGCGTACTC
Bfr-F CTGAACCAGCCAAGTAGCG 16S rDNA [81]
Bfr-R CCGCAAACTTTCACAACTGACTTA
Bifidobacterium
Bif164-f GGGTGGTAATGCCGGATG 16S rDNA [69, 79, 82, 85, 99, 101, 105, 108,
118, 125–127]Bif662-r CCACCGTTACACCGGGAA
g-Bifid-F CTCCTGGAAACGGGTGG 16S rDNA [64]
g-Bifid-R GGTGTTCTTCCCGATATCTACA
ForTal CGTCGCCTTCTTCTTCGTCTC transaldolase gene [74]
RevTal CTTCTCCGGCATGGTGTTGAC
Helicobacter
658f TGGGAGAGGTAGGTGGAAT 16S rDNA [128]
1067R GCCGTGCAGCACCTGTTTTCA
Enterococcus
Ent1017F CCTTTGACCACTCTAGAG 16S rDNA [64]
Ent1263R CTTAGCCTCGCGACT
Lactobacillus groupd
Lac1 AGCAGTAGGGAATCTTCCA 16S rDNA [64, 86, 88, 125, 127, 129, 130]
Lac2 ATTYCACCGCTACACATG
27f (also
Bact-0011f)
AGAGTTTGAT(C/T)(A/C)TGGCTCAG
16S rDNA [79, 98, 118]
Lab-0677r CACCGCTACACATGGAG
Lab-0159f GGAAACAG(A/G)TGCTAATACCG 16S rDNA [98, 118]
Uni-0515-r ATCGTATTACCGCGGCTGCTGGCA
Lab-0159f GGAAACAG(A/G)TGCTAATACCG 16S rDNA [124]
Lab-0677r CACCGCTACACATGGAG
Species group level
Bacteroides fragilis
subgroupe
g-Bact-F ATAGCCTTTCGAAAGRAAGAT 16S rDNA [73]
g-Bact-R CCAGTATCAACTGCAATTTTA
Bact 596F TCAGTTGTGAAAGTTTGCG 16S rDNA [64]
Bact 826R GTRTATCGCMAACAGCGA
Bact 531F ATACGGAGGATCCGAGCGTTA 16S rDNA [90]
Bact 766R CTGTTTGATACCCACACT
Clostridium phylogenetic
clusters XI and XIVaf
Erec 688F GCGTAGATATTAGGAGGAAC 16S rDNA [90]
Erec 841R TGCGTTWGCKRCGGCACCG
a
A GC-clamp is attached to the 5′ end of either the forward or reverse primer.
bPrimers HDA1 and HDA2 have the same core sequence as primers 341 f and 518 r, respectively, but with a few additional nucleotides at both 5′ and 3′ ends.
cPrimer 339f has the same core sequence as primer 341 f but with two additional nucleotides at the 5′ end.
dThe Lactobacillus group comprising the genera Lactobacillus, Leuconostoc, Pediococcus, Weissella, and Aerococcus (the latter genus was originally not described
as target of the Lac1/2 primers).
eThe Bacteroides fragilis subgroup comprising B. fragilis, B. acidifaciens, B. caccae, B. eggerthii, B. ovatus, B. stercoris, B. thetaiotaomicron, B. uniformis, and B.
vulgatus.
fClostridium phylogenetic cluster XI represents the Clostridium lituseburense group, whereas Clostridium phylogenetic cluster XIVa represents the Clostridium
coccoides-Eubacterium rectale group.
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and DGGEK-1001/2001/2401/4001/4801 (CBS Scientific;
http://www.cbsscientific.com/) appear to be most commonly
used. The apparatus provided by Bio-Rad and Ingeny can
also be applied for TTGE analysis whereas for TGGE a
temperature gradient block should be integrated in the
system. In case a high number of samples need to be analyzed
such as in monitoring studies, the sample capacity of the
system is an important criterion. The maximum capacity
per run for the three aforementioned systems varies from
60 (DCode), 96 (INGENYphorU) to 128 (DGGEK-4801)
samples.
In general, DGGE makes use of parallel gel elec-
trophoretic systems that have an increasing vertical gradient
of denaturants parallel to the direction of electrophoresis.
In many studies, the optimal denaturing gradient yielding
the highest resolution is first determined by perpendicular
gradient gels. For this purpose, one sample containing one or
more PCR fragments is electrophoretically separated across
a denaturing gradient perpendicular to the direction of the
electric field resulting in sigmoid-shaped curves. From these
gels, the intermediate range of denaturant concentration,
where diﬀerent electrophoretic mobilities between PCR
products are obtained, is considered the optimal gradient
of denaturants for multilane analysis in parallel DGGE. The
optimal time of electrophoresis can be determined through
a “time travel” experiment during which a mixture of PCR
fragments is loaded onto a parallel gel at constant time
intervals. The optimal duration of a DGGE run can be
derived from the time needed to obtain maximal separation
of amplicons.
A detailed procedure to cast and run DGGE gels has
been described by Muyzer et al. [134, 137]. Essentially, the
desired low and high concentration of denaturing solution
is obtained by mixing zero (0%) and high-concentration
(80–100%) denaturing acrylamide solutions in appropriate
ratios. Upon the addition of ammoniumpersulphate and
tetramethylethylenediamine, the mixture is poured between
two vertical glass plates in order to generate a linear
denaturing gradient. The concentration of acrylamide usu-
ally ranges from 6–12% and depends on the size range
of the fragments to be separated. In general, the high-
concentration denaturing solution contains 7-8M urea and
20–40% formamide. Electrophoresis is mostly carried out in
0.5× or 1× TAE-buﬀer at a fixed voltage between 50V and
250V and a constant temperature between 55 and 65◦C. Run
times generally range from 3–17 hours, although longer run
times with lower voltages tend to produce better quality gels.
In the case of TGGE and TTGE, a linearly increas-
ing temperature gradient parallel to the electrophoresis
direction or formed during the length of electrophoresis,
respectively, is applied in combination with a uniform,
high-denaturant polyacrylamide gel to separate PCR frag-
ments. To determine the temperature range for paral-
lel TGGE or TTGE analysis, a melting profile of the
DNA sequence can be generated using specialized soft-
ware (e.g., Poland analysis software; http://www.biophys.uni-
duesseldorf.de/local/POLAND/poland.html). The optimal
temperature gradient is theoretically delineated by the lowest
and highest Tm values obtained in the melting profile. The
theoretical Tm values can be lowered by adding denaturing
components to the gel, for example, one mole of urea will
lower the theoretical Tm with 2◦C [138, 139]. In general,
a 6–8M urea gel is used in combination with a typical
temperature range between 35 and 70◦C.
Unlike many other fingerprinting methods that make
use of commercially available size standards, SDE techniques
suﬀer from a lack of consensus regarding standards for
normalization. Because denaturing gradients can slightly
vary between diﬀerent gels, a standard reference composed
of amplicons from pure cultures that spans a maximal
range of the applied gradient should be routinely included
at several fixed internal positions on every gel to allow
data normalization and gel-to-gel comparison with a high
degree of confidence. Neufeld and Mohn [140] proposed
an approach which facilitated and improved normaliza-
tion of samples from multiple gels by including stan-
dards in each lane instead of using interlane standards.
These intralane standards contain fluorescent tags incor-
porated in the primers that excitate at another wavelength
than that of the fluorescent molecules attached to the
unknown PCR product. Furthermore, the application of
fluorophore-labeled primers does not require gel stain-
ing following electrophoresis, which improves the overall
sensitivity of the population fingerprinting procedure and
enables additional DGGE versatility including simultaneous
analysis of DNA- and RNA-derived mixtures in the same
lane.
2.4.2. Gel staining
Upon electrophoresis, gels are stained and digitally captured
for further analysis. Three staining agents are commonly
used to visualize fragments. Originally, SDE gels were stained
with ethidium bromide (EtBr) given its widespread use as
an intercalating fluorescent dye used to detect nucleic acids.
The next generation of fluorescent nucleic acid dyes such as
SYBR Green and similar stains oﬀer an increased sensitivity
compared to EtBr due to a lower overall background signal
allowing detection of DNA fragments at lower concentra-
tions [64, 134, 137]. Additional advantages of these newer
dyes are that they are generally considered to be less toxic
or mutagenic than EtBr and can be excited by wavelengths
above 400 nmwhich enables the use of non-UV illumination.
One specific member of the SYBR Green family, SYBR Gold,
binds to both dsDNA and ssDNA. This specific feature
may further enhance the detection sensitivity since DNA
amplicons in the SDE gels are partially single stranded.
Although less commonly applied, silver staining is generally
considered the most sensitive staining procedure. Following
DNA fixation with ethanol and acid (e.g., nitric acid), Ag+
ions in silver nitrate are selectively reduced under alkaline
conditions by formaldehyde to metallic silver (Ag) that is
visualized as a black precipitate. Potential drawbacks of this
procedure include the fact that silver stained gels impede
subsequent blotting experiments or band sequence analysis
and the aspecific detection of protein components such as
BSA and Taq polymerase present in the PCR mix which may
generate additional background signals [134, 137].
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2.5. Data analysis
Normalized SDE fingerprints can be analyzed visually and/or
numerically. Visual interpretation is attainable when only a
limited number of profiles with low complexity are to be
compared. However, once banding patterns become more
complex such as those obtained from intestinal samples
or when the number of profiles increases (e.g., in the
course of monitoring studies), analysis of SDE fingerprints
requires implementation of numerical methods [141]. For
this purpose, digitized SDE gels are further processed using
dedicated image analysis software like GelCompar and BioN-
umerics (Applied Maths; http://www.applied-maths.com/),
Quantity One and Molecular Analyst (Bio-Rad Labo-
ratories), GeneTools (Syngene; http://www.syngene.com/),
and Photo-Capt (Vilber Lourmat; http://www.vilber.com/).
These programs permit numerical analysis of band patterns
and usually also include statistical approaches for data
interpretation. Programs that have been used specifically
for statistical analysis of SDE fingerprint data include R
(http://www.r-project.org/) and DGGESTAT (developed at
the Netherlands Institute for Ecological Research, NIOO-
KNAW, Nieuwersluis, The Netherlands).
2.5.1. Diversity and similarity analysis
Most commonly, numerical analysis of SDE profiles relies on
the use of diversity indices and/or cluster analysis. Diversity
measures for fingerprint analysis such as the Simpson index
and the Shannon-Wiener/Weaver index express the degree of
ecosystem diversity as a function of band profile complexity
but fail to express similarity between profiles based on
band positions. Hierarchic clustering algorithms such as
unweighted pair-group method using arithmetic averages
(UPGMA) produce a visual representation of the similarity
between SDE profiles expressed as similarity indices, for
example, using the curve-based Pearson product-moment
correlation coeﬃcient, the band-based Dice coeﬃcient, or
Sorenson’s pairwise coeﬃcient. Other authors have used
multivariate ordination methods such as nonmetric multidi-
mensional scaling [142, 143], principal component analysis
[109, 144], correspondence analysis [145], canonical variate
analysis [146], and canonical correspondence analysis [147].
These methods are used for integration of complex datasets
such as the bands in an SDE pattern into new mathematical
variables which can be projected into a few-dimension
perspective or reduced space. A more detailed description
of these statistical procedures has been reported elsewhere
[148]. Gafan et al. [149] evaluated the use of logistic
regression for statistical analysis of complex DGGE profiles.
This analysis method takes into consideration the outcome in
addition to diﬀerences in overall band profile complexity and
individual band positions. It is beyond doubt that the list of
numerical approaches and statistical tools for analysis of SDE
profiles will further expand in the coming years. Although
the choice of method(s) is depending on the aim of the
study and on the complexity of the ecosystem, community
fingerprints generally include more information than are
usually revealed with currently available methods. For this
reason, more eﬀorts should be put in the development of new
and extended processing methods for complex SDE data.
2.5.2. Identification analysis
Next to the first SDE analysis level based on the use of
diversity and similarity coeﬃcients, a second level can be
defined that allows one to identify and monitor specific
members of the intestinal ecosystem. Essentially, identi-
fication of individual bands in SDE fingerprints may be
obtained by band position analysis (BPA) and/or through
band sequencing analysis. Essentially, BPA relies on the
comparison of migration distances of band fragments from
taxonomically well-characterized reference strains with those
of unknown bands present in the sample profiles. BPA can
either be performed by analyzing samples and reference
strains in adjacent lanes on the same gel (i.e., comigration
analysis) or by comparing unknown band positions with
those of reference strains present in a user-generated SDE
database. In intestinal ecosystems, BPA-based identification
may not always yield a conclusive result given the possibility
that a single band may consist of multiple amplicons from
diﬀerent species or that two or more (phylogenetically
related) species are characterized by the same band position
in the sample profile. Ideally, each band position in a
sample profile should represent one species. In practice,
however, the multioperon eﬀect observed for some taxa
when using 16S rRNA gene primers may lead to an
overestimation of the number of predominant species in the
sample (e.g., see Section 4.2). In contrast to SDE profiles
obtained with universal primers, identification of bands
in subpopulation profiles by BPA may be more feasible.
Application of SDE using group-specific primers for the
genera Bacteroides [81, 90] and Bifidobacterium [74, 90,
108, 117] showed that species identities can be resolved
by means of BPA. Temmerman et al. [117] described
a protocol to identify bifidobacterial communities based
on a nested-PCR-DGGE approach comprising a Bifidobac-
terium-specific PCR step followed by a second PCR step
in which both the V3 and V6–V8 regions of the 16S
rRNA gene were amplified. A mix of both amplicons
was analyzed on a DGGE gel, after which band positions
were compared with a user-generated database of reference
strains.
Identification results from BPA can or even should be
verified by band sequencing, and may help to determine
the phylogenetic aﬃliation of unknown bands. Various
procedures have been described to excise and recover PCR
fragments from the polyacrylamide gel matrix ranging from
conventional elution in electrophoresis buﬀer to specialized
protocols using diﬀusion buﬀers and commercial kits [74].
A critical postextraction step during this process concerns
the reamplification and subsequent SDE analysis of the
excised fragment together with the original environmental
sample in order to verify if the correct band was extracted.
Upon confirmation, the recovered PCR fragments can be
directly sequenced without additional cloning. Subsequent
identification of the obtained sequence information can be
achieved by comparison with sequences stored in public
8 Interdisciplinary Perspectives on Infectious Diseases
databases, for example, EMBL (http://www.ebi.ac.uk/embl/)
or GenBank (http://www.ncbi.nlm.nih.gov/genbank).
As further discussed below, the significance of the
obtained species information is dependent on the length of
the fragment and the hypervariable region it represents in the
target gene. This sequence information can also be employed
to develop probes for application in FISH and real-time PCR
assays to detect and quantify the target organisms. Next to
sequencing analysis, identities of individual bands in SDE
profiles can also be revealed by Southern hybridization with
taxonomic probes [150].
3. ANALYSIS OF HUMAN INTESTINAL MICROBIOTA
The human intestinal tract harbors a highly dense and
complex microbial community which plays a pivotal role in
maintaining the health status of the gut. Despite the fact
that SDE-based methods only allow a superficial view on
the microbial diversity and population dynamics of what
is considered the predominant part of complex ecosystems,
their use in the field of intestinal microbiology has increased
exponentially over the past 10 years. The following section
aims at reviewing the main contributions of SDE population
fingerprinting to our current knowledge on the composition
and ecological balance of the human intestinal microbiota
linked to health, disease, and dietary intervention.
3.1. Normal intestinal microbiota
Next to a relative minority of organisms belonging to other
microbial domains, the human intestinal microbiota mainly
consists of bacteria. Although the major site of microbial fer-
mentation is the large intestine (colon), bacterial populations
are encountered along the total length of the digestive tract.
Starting from the upper bowel, bacterial concentrations
gradually increase up to 1011-1012/g in the colon. Parallel to
the increase in bacterial density, also the bacterial diversity
expands from the small intestine to the colon [151, 152].
From the community point of view, it is important to
realize that the intestinal ecosystem evolves from an initially
sterile system that becomes successively colonized by various
microorganisms.
3.1.1. From newborn to adult
Several studies have used SDE-based techniques to monitor
the development of the newborn gut microbiota in humans
[6, 96, 101, 102, 106, 107]. At birth, the initially sterile gut
becomes inhabited by a variety of bacterial taxa. Succession
continues during weaning until a more complex and stable
microbiota is established. Two studies by Favier et al. [6,
96] have shown that the intestinal bacterial community of
newborns is extremely unstable as evidenced by the fact that
many dominant bands in DGGE profiles of fecal samples
from healthy full-term babies reduced in intensity, gradually
disappeared after a few days and were substituted by other
bands. In the first weeks of life, DGGE profiles obtained
with universal 16S rRNA gene V6–V8 primers consisted of
only a few bands but progressively increased in complexity
over time. In combination with clone libraries constructed
from 16S rRNA gene sequences, identification of bacterial
species corresponding to specific bands in DGGE profiles
was possible by BPA. This approach indicated that E. coli
and Clostridium spp. were the main groups among the
initial colonizers, which were rapidly replaced by a more
complex microbiota consisting of Bifidobacterium, Clostrid-
ium, Enterococcus, Ruminococcus, Enterobacter, Streptococcus,
Bacteroides, and Actinomyces. The diversity revealed by
DGGE analysis was fairly consistent with previous insights
in infant succession patterns based on traditional culture
studies [5, 7]. In addition, the successive colonization of
the infant gut by bifidobacteria was monitored during the
first five months after birth using Bifidobacterium-specific
primers [96]. Whereas some subjects showed very stable
DGGE profiles, others revealed temporal variation in their
bifidobacterial population. At each point in time, one to
four Bifidobacterium-related DGGE bands were observed
which always included Bifidobacterium infantis. In another
study, the dynamics of the developing bacterial community
in the neonatal intestinal tract of nine Japanese infants
was monitored during the first two months of life [102].
Although the development of individual species was diﬀerent
among the subjects, DGGE profiles of the predominant
fecal microbiota together with 16S rRNA gene clone library
sequencing revealed a global stepwise evolution from an
aerobic to an anaerobic microbial ecosystem. The aerobic
organisms that were initially present such as Pseudomonas
were immediately replaced by facultative anaerobes includ-
ing Enterococcus, Streptococcus, and Enterobacteriaceae dur-
ing the first month. Finally, strictly anaerobic bifidobacteria
and clostridia appeared. The establishment and succession of
bacterial communities in hospitalized preterm infants tend
to follow a diﬀerent pattern compared to full-term infants
[101]. Fecal samples from 29 preterm infants hospitalized
in a neonatal intensive care unit and 15 full-term infants
were analyzed using DGGE to characterize and compare
bacterial succession of the dominant bacterial species in
the large intestine. In the first four weeks of life, DGGE
patterns increased in complexity over time for all preterm
infants. During this observation period, the intraindividual
band pattern similarity increased over time as indicated
by an increase in Sorenson’s pairwise similarity coeﬃcient
(Cs) from 0 to 80%. In addition, also the interindividual
Cs values increased (18.1 to 57.4%) all of which indicated
the acquisition of a highly similar bacterial community in
these infants. In contrast, breastfed full-term infants showed
a considerably lower interindividual Cs value (11.2%). The
strikingly high similarity between bacterial communities
from diﬀerent preterm infants was considered to be associ-
ated with hospitalization because the major bacterial groups
identified by DGGE BPA belonged to taxa that are routinely
isolated in baby care units such as E. coli, Enterococcus spp.,
and Klebsiella pneumoniae. This finding thus indicates that
the initial colonization of the newborn’s intestinal tract is
highly dependent on the immediate environment of the
individual. In another study assessing the global diversity
of the fecal microbiota of preterm infants (n = 16), a
remarkably low-species diversity and high-interindividual
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variability were reported [106]. The low-bacterial diversity
was revealed by random sequencing of 16S rRNA gene clones
and TTGE analysis. The main fecal groups encountered here
includedmembers of the Enterobacteriaceae family and of the
genera Enterococcus, Streptococcus, and Staphylococcus. Seven
out of 16 preterm infants were colonized by anaerobes, of
which four infants were shown to harbor bifidobacteria.
Several studies have documented that bifidobacteria
predominate in the fecal flora of breastfed babies, whereas in
formulafed infants, other bacterial groups such as coliforms,
enterococci, and Bacteroides represent the main constituents
[7, 153]. In contrast, the possible eﬀect of dietary supplemen-
tation in the intestinal development of nursing infants is less
well understood. In a longitudinal study, TTGE was used to
monitor the predominant and bifidobacterial microbiota of
11 Algerian infants during breastfeeding, breastfeeding with
artificial milk supplementation (weaning) and artificial milk
alone (postweaning, i.e., cessation of breastfeeding) [107].
In the TTGE profiles, the major bands were assigned by
subsequent cloning and sequencing to E. coli, Ruminococ-
cus spp., and several Bifidobacterium species including B.
longum, B. infantis, and B. breve. Both for the bacterial and
bifidobacterial TTGE profiles, distance analysis indicated the
expected maturation of the faecal microbiota between 5 and
20 weeks of age, but did not reveal any correlation with
the dietary supplementation. Despite a high-interindividual
variability, it was observed that the composition of the faecal
microbiota appearedmore homogenous after weaning which
may suggest a correlation with the cessation of breastfeeding.
In another study, 65 10-month old infants were included in
a randomized dietary intervention study that compared the
eﬀect of cow’s milk (CM) with infant formula (IF) with or
without fish oil (FO) supplement on the diversity of the fecal
microbiota [80]. Based on clustering analysis of V3- and V6–
V8-16S rDNA DGGE profiling using the Pearson correlation
coeﬃcient, it was reported that supplementation of CM or
IF appeared to have an influence on the composition of
the intestinal microbiota whereas FO intake only showed an
eﬀect in the CM group. The authors speculated that these
diﬀerences may be influenced by the intake of iron and n-3
polyunsaturated fatty acids, respectively, but further indepth
analysis of the DGGE profiles in combination with other
molecular tools is required to substantiate this hypothesis.
Besides the influence of environmental and dietary
factors, also the host genotype may have a significant eﬀect
on the species composition of the intestinal microbiota.
Stewart et al. [84] used TTGE analysis of the predominant
bacterial biota to investigate the influence of host genotype
on the fecal microbiota in genetically related and unrelated
children. In that study, TTGE profiles of identical twin pairs
(n = 13), fraternal twin pairs (n = 7), and unrelated control
pairs (n = 12) were compared both visually and numerically.
Although the community fingerprints of each individual
were unique, increased levels of similarity were found
between TTGE profiles of genetically related individuals,
with the highest similarity values obtained for genetically
identical twins (median Cs of 82%) which was significantly
diﬀerent from fraternal twin pairs (median Cs of 68%) and
from the unrelated control group (median Cs of 45%). The
results of this TTGE study thus suggested that host genetics
can have an impact on the composition of the predominant
fecal bacterial community in children. Likewise, DGGE
analysis of the dominant intestinal microbiota amongst
adults displaying varying degrees of genetic relatedness
showed that the host genotype had a significant eﬀect on the
species composition of the intestinal community [122].
Upon succession, it is thought that a relatively stable
intestinal community is established in the adult intestine that
appears to be specific for each individual. Zoetendal et al.
[95] were the first to report on the stability and uniqueness
of the predominant human adult fecal microbiota that can
be visualized with SDE-based approaches. TGGE analysis of
fecal samples from two healthy individuals showed stable
profiles over a period of at least six months which in addition
were unique for each individual. These findings were con-
solidated in a later study [64] in which the host specificity
and temporal stability of the DGGE patterns was demon-
strated for four subjects over a 16-week period by visual
inspection and clustering analysis. In the latter study, also the
temporal stability of selected subpopulations was monitored
using group-specific primers. DGGE profiles obtained with
primers designed to visualize the Lactobacillus-Leuconostoc-
Pediococcus-Weissella-group tended to show strong temporal
variations. Among other autochthonous groups such as the
Bacteroides fragilis subgroup, however, DGGE profiling using
group-specific primers did not reveal such variations. Impor-
tantly, the specificity of these group-specific primers was only
validated using a set of taxonomic reference strains. A more
elaborated strategy was followed in the validation of DNA-
and RNA-based DGGE protocols specifically designed to
assess the diversity and stability of the Clostridium coccoides-
Eubacterium rectale (clostridial phylogenetic cluster XIVa)
group in fecal samples [70]. In that study, the specificity of
the Ccoc-f and Ccoc-r primers was assessed by constructing
a clone library in which all 205 DGGE fragments proved
to belong to the Clostridium cluster XIVa. The authors
concluded that the members of this cluster, representing
one of the most dominant bacterial groups in the normal
intestinal microbiota, followed the same pattern of relative
stability as the total predominant population in 12 healthy
Finnish adults during six months to two years. Although
using protocols diﬀering in sample type, SDE method and
primer target, the current view on the uniqueness and
temporal stability of the predominant intestinal flora in
adult individuals has also been confirmed in other human
volunteer studies using SDE-based analyses of fecal samples
[77, 81, 83, 98, 99, 118, 154] and mucosa samples originating
from diﬀerent parts of the large intestine [79, 98, 123].
Although the vast majority of SDE-based studies in
intestinal microbiology rely on direct DNA extraction from
human samples in order to obtain a culture-independent
inventory of the microbial diversity, there has also been
interest in using DGGE and related fingerprinting tech-
niques to specifically explore the composition of culturable
intestinal subpopulations. For instance, DGGE analyses of
resuspended bacterial biomass obtained from agar plates
of diﬀerent media selective and nonselective for lactic acid
bacteria (LAB) have been used to evaluate the choice of
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medium and incubation conditions on LAB recovery and to
gain insight in the diversity of culturable fecal LAB in healthy
adults [129].
3.1.2. Spatial distribution
The diﬀerent physicochemical conditions such as pH and
concentration of fermentation products prevailing in the
ascending, transverse, and descending parts of the colon
[155] suggest that also the bacterial composition in each
of these three compartments is unique. However, this
assumption is not substantiated by SDE-based studies [30,
79, 91, 115, 123]. In most of these studies, DGGE and TTGE
fingerprint profiles reflecting the predominant bacterial
communities in biopsy samples from diﬀerent sites of the
colon were host specific but highly similar between sites.
These findings may indicate that the spatial distribution of
at least the predominant mucosa-associated bacterial com-
munity is relatively uniform along the length of the colon
and its physicochemical gradient. Nielsen et al. [79] reported
that DGGE profiles of the bifidobacterial community were
relatively simple and consisted of one or two bands for most
of the sites sampled along the length of the colon. However,
the mucosa-associated subcommunity encompassing the
genera Lactobacillus, Leuconostoc, Weissella, Pediococcus, and
Aerococcus produced relatively complex DGGE profiles that
varied between hosts and between sampled sites in the
colon. In contrast, Zoetendal et al. [123] obtained DGGE
profiles with low diversity and little or no variation along
the colon when using the same set of group-specific PCR
primers. Presumably, the contradictory findings of the two
aforementioned studies are due to diﬀerences in sampling
procedure, DNA extraction method, and/or composition of
the subject group.
Given the fact that each individual displays a unique fecal
SDE fingerprint [64, 95], investigation into spatial distribu-
tion should preferably be based on analysis of a series of site-
specific biopsy samples from the same individual. To some
extent, this may explain why interindividual comparison of
DGGE profiles of single biopsy samples from diﬀerent sites
did not provide any evidence for the existence of site-specific
colonization patterns in the human colon [30].
A number of studies have also investigated to what
extent the composition of the fecal microbiota reflects the
composition of the mucosa-associated colonic microbiota
[91, 123]. In these studies, the DGGE/TTGE profiles of
amplicons of the variable V6–V8 region of the 16S rRNA
gene reflecting the predominant bacterial community of
biopsy samples diﬀered significantly from those of fecal
samples within the same individual, suggesting that diﬀerent
bacterial populations are dominating the human mucosa
and feces. The population diversity revealed by SDE-based
community fingerprinting of fecal samples may thus not
necessarily reflect the ecosystem composition in other parts
of the intestinal tract including the colonic mucosa. This
leads to the conclusion that the most accurate information
on the diversity and stability of local intestinal communities
can thus only be obtained by taking samples through
endoscopy or during colonic surgery.
3.2. Intestinal disorders
The pathogenesis of many chronic intestinal disorders and
even a number of nonintestinal diseases is believed to be
directly or indirectly linked to some members of the indige-
nous microbiota. Several studies have implemented an SDE-
based approach to analyze and monitor the composition and
temporal stability of the intestinal microbiota of patients
suﬀering from gut disorders. As an initial approach, SDE
techniques permit a rapid and global assessment of microbial
diversity without previous knowledge of the composition
and are well suited to analyze intestinal microbiota in relation
to diﬀerent experimental conditions and parameters such as
healthy versus disease status, active versus quiescent disease
phase, diﬀerent segments of the intestinal tract and response
to nutritional or therapeutic interventions. Moreover, the
combined use of SDE techniques and quantitative assays
such as real-time PCR and FISH that allow to determine
the relative concentration of specific indicator organisms
oﬀers great potential in this type of studies. The following
sections of this review are based on a selected number
of studies that have implemented SDE-based methods to
assess the potential role of the intestinal microbiota in the
(etio)pathogenesis of chronic intestinal disorders.
3.2.1. Inflammatory bowel disease
Although the exact etiology of inflammatory bowel disease
(IBD) is not known to date, it is generally assumed to result
from an inappropriate response of the mucosal immune
system to the normal enteric microbiota in a genetically
susceptible individual [156]. It has been hypothesized that
specific genetic polymorphisms, such as those in intracellular
NOD2 sensors with abnormal function, results in a failure to
eﬃciently regulate expression of Paneth cell-derived antimi-
crobial peptides [157, 158]. The partial loss of this protective
function may allow commensals to damage epithelial cells
hereby inducing an inflammatory response. Crohn’s disease
(CD) and ulcerative colitis (UC) are the two major IBD
phenotypes and are characterized by chronic inflammation
of the intestinal tract lining which causes severe watery and
bloody diarrhoea and abdominal pain [156]. Whereas CD
can virtually aﬀect any segment of the intestinal tract, UC
is usually confined to the colon and rectum.
The majority of SDE-based studies on IBD have pri-
marily attempted to find diﬀerences between CD/UC and
healthy fecal or mucosal populations. As such, V3–V5-16S
rDNA DGGE profiling and subsequent band sequencing
analysis of fresh mucosal biopsy samples revealed a signifi-
cantly higher prevalence of Clostridium spp., Ruminococcus
torques, and E. coli in samples from CD patients (n =
19) compared to healthy specimens (n = 15) [159]. In
turn, the butyrate-producing Faecalibacterium prausnitzii
wasmore frequently encountered in the latter group. Overall,
DGGE fingerprints of mucosal CD populations displayed
a higher patient-to-patient variability compared to healthy
subjects. The authors postulated that this diﬀerence may
reflect the diﬃculty of patients genetically predisposed to
CD to maintain and regulate a stable intestinal microbiota.
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A study of Bibiloni et al. [160] showed that the phylogenetic
composition of biopsy-associated bacteria diﬀered between
newly diagnosed untreated CD (n = 20) and UC patients (n
= 15) and healthy subjects (n = 14). Biopsies collected from
inflamed and noninflamed sites of the terminal ileum and
various colonic regions were analyzed by DGGE, 16S rRNA
gene clone libraries, and qualitative and quantitative PCR
for detection of selected bacterial groups. DGGE profiles of
universal V3-16S rRNA gene amplicons were very similar
within each subject (mean 85.0 ± 2.4%), irrespective of the
intestinal region. However, enumeration by quantitative PCR
revealed approximately double numbers of biopsy-associated
bacteria for UC patients than CD patients and healthy
subjects. In addition, the clone library composition indicated
that the composition of biopsy populations in UC and CD
patients (P < .05), and those from healthy subjects (P =
.05) were statistically diﬀerent. This comparison highlighted
a significantly higher prevalence of unclassified members of
the phylum Bacteroidetes in CD patients, whichmay indicate
that UC and CD are bacteriologically distinct diseases.
Depending on the individual eﬀectiveness, IBD patients
undergoing immunomodulatory therapy continuously bal-
ance between active disease and remission status. However,
it is unclear if and in what way the intestinal microbiota
of these patients undergoes compositional changes during
these subsequent transitions. In this context, Seksik et al.
[24] monitored the fecal microbiota of patients with active
colonic CD (n = 8), patients in remission (n = 9), and
healthy volunteers (n = 16). TTGE profiles of universal
16S rRNA gene V6–V8 amplicons were very stable over
time in the healthy controls but varied markedly for a
number of patients (n = 4) who were monitored during
both active and quiescent phase of CD. Fecal TTGE profiles
of these four patients revealed only a slight decrease in
the number of bands during the active phase (mean loss
of 1.7 ± 2.7 bands), which indicated that the predominant
fecal microbiota retained a high degree of diversity in both
phases. Based on TTGE band profile composition, no specific
bacterial groups could be assigned to active or quiescent CD
state. In contrast, quantitative dot blot hybridization of stool
samples showed that the fecal microbiota in patients with CD
(both active and inactive) diﬀered considerably from those
of healthy subjects. Both the Bacteroides group (including
the genera Bacteroides, Prevotella, and Porphyromonas) and
the bifidobacteria tended to be less represented in CD
patients whereas significantly more enterobacteria could be
detected. In addition, approximately 30% of the endogenous
microbiota of CD patients did not belong to the dominant
phylogenetic groups commonly found in healthy controls.
Although currently available data from SDE profiling and
other molecular tools implicate a role of intestinal bacteria in
CD pathogenesis, a detrimental eﬀect of localized qualitative
dysbiosis in CD-associated ulceration has so far not be
demonstrated by community fingerprinting. TTGE analysis
of biopsy samples of ulcerated and adjacent nonulcerated
mucosa of 15 patients with active CD did not reveal
qualitative diﬀerences in the dominant bacterial population
profiles (V6–V8 region of the 16S rRNA gene) within a given
patient although a high biodiversity was retained in both
cases [92]. Mean similarity values between TTGE profiles
of ulcerated and nonulcerated mucosa expressed with the
Pearson correlation coeﬃcient did not diﬀer significantly
across the diﬀerent intestinal segments (ileum, right colon,
left colon, and rectum) analyzed and ranged from 95.2 ±
4.2% to 97.9 ± 1.7%. Solely based on TTGE analysis using
universal primers, it thus appears that local ulceration is
not associated with pronounced variation in local bacterial
diversity. This conclusion was further substantiated in a
later study by the same group on the basis of V3-V4-
16S rDNA TTGE profiling and FISH analysis [94]. Also in
other studies applying SDE-based population fingerprinting,
no particular mucosa-associated microbial pattern could be
linked to the (etio)pathogenesis of IBD [91, 123]. Possibly,
local dysbiosis among less predominant species may play a
role in the pathogenesis of ulceration. Because these minor
diﬀerences in diversity will largely remain undetected in SDE
fingerprinting using universal PCR primers or are diﬃcult to
reveal by routine methods for band pattern analysis, future
studies should employ group-specific primers to focus on
the composition of specific subpopulations and/or should
use more indepth mathematical approaches for diﬀerential
profile analysis.
Whereas most studies concentrated on the inventoriza-
tion and monitoring of bacterial groups potentially associ-
ated with CD, very few studies aimed to address the same
question within the metabolically active compartment of the
gut microbiota. Sokol et al. [93] analyzed the biodiversity
of active bacteria in the dominant fecal microbiota of UC
patients (n = 9) in comparison with that of healthy subjects
(n = 9) by applying DNA- and RNA-based TTGE analysis
of V6–V8 ribosomal amplicons. The number of bands in
DNA-derived TGGE profiles were significantly higher than
in RNA-derived profiles for UC patients (15.3 ± 3.2 and
9.1 ± 2.8 bands, resp.) but not for controls (18.3 ± 5.0 and
14.7 ± 5.1 bands, resp.) which indicated a reduction in the
biodiversity of the active portion of the fecal microbiota in
UC patients relative to healthy controls. Irrespective of the
initial template (RNA or DNA), Pearson-UPGMA clustering
analysis of TGGE profiles tended to group the samples on
the basis of their clinical aﬃliation (UC versus controls)
suggesting that each group has its specific bacterial signa-
ture. Interindividual comparison of the “active” microbiota
(RNA-derived profiles) revealed a band that was significantly
associated with UC patients (89% versus 22% for controls).
Sequence analysis attributed this band to E. coli or related
enterobacteria. Clearly, the possible pathophysiological role
of this overrepresentation in the active microbiota of UC
patients should be further assessed during remission and
within the mucosa-associated microbiota.
3.2.2. Other intestinal disorders
Irritable bowel syndrome (IBS) is an intestinal disorder
that is characterized by bowel dysfunction and pain [161,
162]. IBS is a very heterogeneous condition and includes
three symptom categories: (i) diarrhoea-dominant, (ii)
constipation-dominant, and (iii) alternating type [163, 164].
Although the pathophysiology of IBS is not fully understood,
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it is highly probable that alterations in the diversity and
stability of intestinal microbiota play a role in the devel-
opment and/or maintenance of this disorder [165]. In a
Finnish study [121], culture-based techniques and DGGE
analysis were employed to compare the composition and
temporal stability of the fecal microbiota of 21 IBS patients
and 17 healthy controls. Culturing revealed slightly higher
coliform numbers as well as an increased aerobe/anaerobe
ratio in the IBS group. DGGE analysis of 16S rRNA gene
V6–V8 amplicons revealed considerable biodiversity and
subject specificity of the predominant microbiota in both
study groups, but did not identify IBS-specific bacterial
groups. Visual comparison of DGGE fingerprints revealed a
higher frequency of temporal instability in the predominant
bacterial population of IBS subjects (43%) compared to
controls (29%). However, profile similarity analysis using
the Pearson correlation coeﬃcient revealed comparable
interindividual similarity percentages for both groups with
a mean similarity of 87.5 ± 11.2% for the IBS group and
85.7 ± 12.7% for the control group. Still, the instability
in some of the IBS subjects could partly be explained by
disturbances of the intestinal microbiota due to antibiotic
therapy during the study. Moreover, the authors suggested
that these findings could be associated with a subset
of IBS subjects sharing specific symptoms and thus not
necessarily reflect the general microbial status of all IBS
patients. In this regard, future studies should include subject
groups with well-defined symptom-based IBS parameters
to evaluate the association of intestinal instability with
specific IBS symptoms or with specific bacterial groups and
species. In a subsequent study of the same group [71], the
predominant and clostridial fecal microbiota of IBS patients
and healthy controls were compared to reveal possible
diﬀerences in the composition, abundance, and stability of
selected groups by applying DNA- and RNA-based DGGE
analyses and transcript analysis with the aid of aﬃnity
capture, a multiplexed and quantitative hybridization-based
technique. Clostridia, that is, C. histolyticum, C. coccoides-
Eubacterium rectale, C. lituseburense, and C. leptum, were
shown to represent the dominant fecal microbiota in 26
of the 32 subjects under study, contributing altogether 29–
87%. The proportion of the C. coccoides-E. rectale group
was found to be significantly lower in the constipation-
type IBS subjects compared to the controls. Although DNA-
and RNA-derived predominant community profiles showed
considerable biodiversity and subject-specificity, RNA-based
DGGE profiles contained significantly fewer amplicons (16±
5 compared to 22 ± 5 amplicons). In addition, only RNA-
based DGGE profiles of the IBS subjects indicated higher
instability of the bacterial population compared to the con-
trol subjects. Although intraindividual temporal instability
of the predominant microbiota was observed in both IBS and
control subjects (with both DNA- and RNA-based DGGE),
only RNA-derived DGGE profiles of IBS subjects showed a
broader range in similarity values (39–95%) compared to
control subjects (68–94%). When considering symptomatic
IBS subgroups, the largest intraindividual variability in
DGGE similarity values was observed in the diarrhoea-type
subgroup. These observations suggest that clostridial micro-
biota, in addition to the instability of the active predominant
fecal bacterial population (RNA-derived profiles), may be
involved in IBS. For future research, the use of group-specific
primers in SDE analysis focussing on apparently aﬀected
groups (e.g., coliforms and clostridia) could be a valuable
and eﬀective approach to identify potential IBS indicator
organisms.
The use of SDE-based methodologies to determine
the diversity and stability of microbiota in inflammatory
diseases has meanwhile expanded from IBD and IBS to
other intestinal diseases in which dysbiosis of the human
microbiome is thought to play a role such as neonatal
necrotizing enterocolitis [116] and coeliac disease [130]
or diseases beyond the intestinal system such as (atopic)
allergies [82, 85, 166] and ankylosing spondylitis [113].
3.3. Intervention studies
Apart from components naturally occurring in a normal
diet, also functional foods (including pre- and probiotics)
and antimicrobial agents are able to induce beneficial or
detrimental changes in intestinal ecosystems. Starting from
the first weeks upon birth, the human diet is able to
modulate the composition and balance of the intestinal
microbiota [7, 153]. The SDE approach is routinely applied
in administration studies to monitor the eﬀects on the
intestinal microbiota upon consumption of various active
components.
3.3.1. Functional foods
The fact that diet is a major factor controlling the human
intestinal balance has triggered the development of a new
generation of foods specifically designed to strengthen the
gut microbiota via modulation. Functional foods include
foods and food products with a clearly identifiable health
benefit in addition to their basic nutritional value [167].
In functional foods, the addition or incorporation of pro-
and/or prebiotic components as active ingredients plays a
key role in functional applications aiming at modulation
of intestinal microbiota. According to the FAO/WHO def-
inition [168], probiotics are live microorganisms which,
when administered in adequate amounts, confer a health
benefit for the host. An extended version of this definition
is still under debate, including the question whether the
live status is truly required for probiotic action [169, 170].
Beneficial eﬀects induced by probiotic activities are mediated
either through modulation of the indigenous microbiota or
through the immunomodulatory potential of the probiotic
strains used. Bacterial cultures incorporated in probiotic
products for human consumption commonly—but not
exclusively—originate from the intestinal system of healthy
(human) subjects and most frequently belong to the bifi-
dobacteria and to LAB such as Lactobacillus spp. A prebiotic,
on the other hand, is a nondigestible selectively fermented
compound that induces specific changes both in the compo-
sition and/or the activity of the gastrointestinal microbiota
thereby conferring benefits upon host well-being and health
[171]. Essentially, the functionality of a prebiotic compound
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Table 3: Selection of dietary intervention studies using SDE-based community fingerprinting.
Componenta Administered component Reference(s)b
p Levan-type exopolysaccharides, levan, inulin and FOS [111]
p GOS and FOS [75]
p Difructose anhydride III (DFA III) [72, 73]
P Lactobacillus rhamnosus DR20 [76, 88]
P Lactobacillus paracasei F19 [98]
P VSL#3 (probiotic mixture of eight strains) [110]
P Bifidobacterium longum (Bifina) and yogurt with Bifidobacterium animalis DN-173 010 [179]
y Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus [68]
p, P Inulin or B. longum (Bifina) [180]
pP Inulin-containing probiotic yogurts [127]
pP GOS-containing probiotic yogurt [69]
p, P, pP GOS and/or Bifidobacterium lactis Bb-12 [100]
p, P, pP Lactulose and/or Saccharomyces boulardii [90]
o Black tea [120]
o, op, oP Isoflavones and FOS or B. animalis DN-173 010 [105]
a
p: prebiotic; P: probiotic; pP: synbiotic; y, yogurt; o: other.
bAll studies used DGGE as SDE method except in [105], where TTGE was used.
is determined by its potential to stimulate beneficial bacteria
indigenous to the gut ecosystem. Complex oligosaccharides
are most commonly used as prebiotics including lactulose,
galactooligosaccharides (GOS) and fructooligosaccharides
(FOS; e.g., oligofructose and inulin). A wide range of benefi-
cial eﬀects have been attributed to probiotics, prebiotics, or a
combination thereof (i.e., synbiotics), including modulation
of the gut immune system, resistance to microbial infections,
antimutagenic/anticarcinogenic eﬀects, reduction of blood
ammonia and cholesterol levels, prevention and/or allevia-
tion of diarrhoea and constipation, prevention and reducing
symptoms of intestinal chronic disorders, relief of lactose
intolerance and increased mineral absorption as reviewed in
[172–178].
SDE-based methods have played a key role in human
dietary intervention studies aiming at demonstrating the
eﬃcacy of functional food components and to substantiate
potential health claim. A selection of relevant studies that
have contributed to this field is listed in Table 3 [68, 69,
72, 73, 75, 76, 88, 90, 98, 100, 105, 110, 111, 120, 127,
179, 180]. Solely based on findings from SDE analysis, it
appears that prebiotic administration can potentially aﬀect
the predominant bacterial population of healthy human
subjects, whereas most probiotic interventions only seem
to induce marked eﬀects in patient groups. This could
indicate that some probiotic components may have more of
a therapeutic eﬀect in subjects with a disturbed intestinal
balance but less eﬀective as general health promoting agents.
On the other hand, it should be kept in mind that SDE-
based approaches focus on diversity and dynamics of pre-
dominant intestinal microbiota, and are as such unsuitable
to monitor probiotic interventions that are based on the
immunomodulatory potential of the administered organ-
ism(s). Bibiloni et al. [110] used DGGE to evaluate the safety
and eﬃcacy of the mixed probiotic preparation VSL#3
(http://www.vsl3.com/) consisting of three Bifidobacterium
strains and five LAB strains (i.e., four Lactobacillus strains
and one Streptococcus thermophilus strain) in patients with
active mild to moderate UC. DGGE analysis of V3-16S
rRNA gene amplicons generated from biopsies collected
from seven patients before and after 6-week VSL#3 admin-
istration revealed considerable variation of the predominant
microbiota in four out of five patients in remission (mean
dice similarity coeﬃcient (Ds) of 69.9± 12.7%). In contrast,
the DGGE profiles of the two patients with continued active
disease remained relatively stable after VSL#3 consumption
(mean Ds of 92.3 ± 4.1%). Importantly, it should be noted
that the study did not report on the temporal stability
of biopsy profiles in the absence of probiotic treatment.
In another study, the eﬀect of a 4-week administration
of the candidate prebiotic di-D-fructofuranose-1, 2′ : 2,
3′-dianhydride (DFA III) on human fecal microbiota was
studied by DGGE analysis using universal V3-16S rRNA
primers and Bacteroides fragilis subgroup-specific primers
[73]. Visual and numerical analysis of the DGGE profiles
generated with both primer sets revealed no pronounced
changes related to DFA III administration in healthy subjects.
In a followup long-term human feeding trial (2 to 12
months) with DFA III, however, DGGE profiles of the pre-
dominant bacterial population revealed a marked increase
in the intensity of bands related to Bacteroides spp. [72].
In a study on the eﬀect of 3-week consumption of a GOS-
containing probiotic yogurt on the diversity and temporal
stability of fecal microbiota in elderly [69], DGGE revealed
that the predominant bacterial population and the Clostrid-
ium coccoides-Eubacterium rectale group remained relatively
stable during the study period. In contrast, the Lactobacillus
group showed temporal variation which confirms previous
observations under basal conditions [64].
In the course of probiotic intervention studies, DGGE
and related fingerprinting techniques have been used to
verify if the administered strain(s) is (are) detectable in
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intestinal samples [76, 88, 98, 100, 105, 110, 125, 179].
Based on a combination of culture-based methods and 16S
rDNA DGGE, Wall et al. [86] even reported the recovery
of probiotic strains Lactobacillus paracasei NFBC 338 and
B. animalis subsp. lactis Bb12 in ileostomy eﬄuents of
two infants without a history of probiotic intake. In this
context, it should be noted that SDE fingerprinting is not
the most optimal tool for detection of administered strains
because of the relatively poor detection limit (especially
when using universal primers) and the lack of resolution to
discriminate the introduced strain(s) from other strains of
the same or highly related autochthonous member species
of the intestinal microbiota. More suitable approaches are
those applying strain-specific primers (e.g., conventional or
real-time PCR) or probes (e.g., fluorescent FISH probes)
which will not only provide a higher sensitivity but may
also allow relative quantification of the probiotic target [181–
184]. On the other hand, it should be kept in mind that
all aforementioned DNA-based approaches do not allow to
discriminate between living and dead cells and thus do not
provide information on probiotic survival throughout the
gastrointestinal tract.
In recent years, SDE-based community fingerprinting
has been integrated in larger polyphasic studies in com-
bination with conventional culture methods and/or with
other molecular culture-independent methods to detect
and monitor changes in human intestinal ecosystems upon
administration of probiotic, prebiotic, or other (in)organic
compounds with claimed functionalities. As such, DGGE
and FISH approaches were combined with selective culture
methods to evaluate the impact of a 3-week diet supple-
mentation with prebiotic GOS or FOS on the composition
and activities of the fecal microbiota of 15 healthy human
volunteers [75]. V3-16S rRNA gene DGGE profiles remained
relatively stable during the study, whereas clear alterations
in response to dietary supplementation were observed in
rRNA-DGGE profiles as evidenced by the detection of
additional fragments or increased staining intensity of band
fragments attributed to Bifidobacterium adolescentis and/or
Collinsella aerofaciens. In contrast, DGGE analysis using
genus-specific primers derived from the transaldolase gene
generated relatively stable profiles for fecal bifidobacteria.
Although the taxonomic composition of the bifidobacterial
population was not substantially diﬀerent and both DGGE
and FISH revealed that the Bifidobacterium and Collinsella
populations remained relatively unchanged, rRNA-DGGE
provided evidence of increasedmetabolic activity in response
to prebiotic consumption. A combination of DGGE and
FISH was also used to investigate the eﬀect of black tea
drinking on the fecal microbiota of healthy volunteers with
hypercholesterolemy [120]. DGGE of 16S rRNA gene V6–
V8 amplicons showed that each subject harboured a specific
predominant bacterial population that exhibits little change
over time and that was not significantly changed by drinking
black tea. Even though black tea did not aﬀect the specific
bacterial groups analyzed by FISH (i.e., Bifidobacterium,
Bacteroides and Prevotella, Clostridium phylogenetic clus-
tersIV and XIVa, Atopobium group, Faecalibacterium-like
species and E. coli), it did decrease the total amount of
bacteria detected by the universal bacterial probe. In a
study that combined the use of TGGE and FISH analysis,
it was demonstrated that isoflavone supplementation with
and without pro- or prebiotics induced significant dynamic
changes on the composition of the dominant intestinal
microbiota of 39 postmenopausal women [105]. Results
of FISH analysis indicated that several of the dominant
fecal groups were stimulated by isoflavones alone, whereas
TGGE profiling of 16S rRNA gene V6–V8 amplicons revealed
marked changes in the predominant intestinal microbiota.
Intraindividual comparison of TGGE fingerprints showed
a mean Pearson similarity value of 73% before and after
one month of isoflavone supplementation. In combination
with a pro- or prebiotic compound, isoflavones triggered
comparable population changes as evidenced by mean
fingerprint similarity values of 71 ± 18% and 68 ± 16%
obtained for the probiotic (Bifidobacterium animalis DN-
173 010) and the prebiotic (FOS) test groups, respectively.
In addition, FISH results showed a bifidobacterial increase
following prebiotic supplementation, often referred to as
the bifidogenic eﬀect. Amongst others [76, 125, 180], the
aforementioned studies have demonstrated the potential of
using SDE fingerprinting and FISH analyses in a comple-
mentary approach to characterize basic interactions between
intestinal microbiota and functional food compounds and
to quantify subpopulations responding to the introduced
component(s).
Next to FISH, also real-time PCR has been used in
combination with DGGE to verify and substantiate com-
positional changes in a semiquantitative manner. The latter
two methods were used in an integrated approach to mon-
itor and quantify pronounced changes in fecal microbiota
of healthy subjects upon long-term administration of a
prebiotic (lactulose), a probiotic (Saccharomyces boulardii),
and their synbiotic combination [90]. Although the DGGE
profiles obtained with the universal V3-16S rRNA gene
primers as well as those generated using group-specific
primers targeting the Bacteroides fragilis subgroup, the
genus Bifidobacterium and the Clostridium lituseburense and
Clostridium coccoides-Eubacterium rectale groups remained
fairly stable, one pronounced change was observed in the
universal fingerprint profiles after lactulose ingestion. The
DGGE band appearing or intensifying in 27 of the 30
subjects could be assigned to Bifidobacterium adolescentis by
band position analysis and band sequencing. In subsequent
real-time PCR analysis, this finding was correlated to a
statistically significant stimulation of total bifidobacteria
and of B. adolescentis. In contrast, the probiotic yeast S.
boulardii did not display any detectable universal changes
in the DGGE profiles nor influenced bifidobacterial levels.
In a double-blind crossover study on the qualitative and
quantitative eﬀects of fresh and heat-treated yogurt on
the bacterial intestinal microbiota from healthy subjects
[68], DGGE profiling revealed overall stability of the pre-
dominant bacterial population and the LAB population at
baseline, after fresh yogurt intake and after heat-treated
yogurt intake. However, real-time PCR with group-specific
primers indicated a significantly higher density of LAB and
Clostridium perfringens and a significant decrease in the
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density of Bacteroides after consumption of both types of
yogurt.
3.3.2. Antimicrobial agents
Apart from their generally well-documented therapeutic
eﬀects on the site of infection, antimicrobials can also exert
a detrimental eﬀect on the microbial balance of the gut
ecosystem. So far, studies analyzing the eﬀect of antibiotic
therapy on the selection and transmission of antibiotic
resistance among pathogens and commensals within the
human intestinal microbiota have mainly relied on culture-
dependent approaches [185–187] which are highly restricted
by the selectivity of the media used. In this respect, SDE-
based techniques provide a more suitable approach to
monitor the eﬀects of antimicrobial agents on the total
community structure of intestinal microbiota.
In several human studies mostly focussing on infant
populations, DGGE analysis has revealed drastic alterations
among the indigenous bacterial diversity upon therapy with
various antimicrobials [77, 96, 101, 102]. Antimicrobial-
induced disruptions of fingerprinting profiles were generally
accompanied by a reduction in band numbers suggesting
an overall decrease in predominant intestinal ecosystem
diversity. Favier et al. [96] monitored bacterial succession
of the intestine during the first four months of life of
five babies, including one infant who received continuous
antibiotic therapy consisting of Augmentin (a mixture of
clavulanic acid and amoxicillin) for 13 days followed by
Bactrimel (a mixture of trimethoprim and sulfamethoxazol)
to combat urinary reflux. During the first month after
birth, the universal 16S rRNA gene V6–V8 DGGE profiles
of the antibiotic-treated baby were highly unstable. Main
bacterial groups were identified as E. coli and Enterococcus
spp., despite the fact that the administered antibiotics were
expected to suppress enteric bacteria. After one month,
DGGE patterns indicated the presence of a simple but
remarkably stable community until the end of the study.
The most significant diﬀerences between the profiles from
the antibiotic-treated baby and the other four healthy babies
related to the absence of Bifidobacterium bands in spite of
a partly breast-milk diet. Likewise, a study in which nine
Japanese infants were monitored during the first two months
after birth demonstrated that antibiotic treatment at the
beginning of life exhibits a strong influence on the estab-
lishment of a normal microbial ecosystem in the intestine
[102]. Two infants who received Cefalex (a cephalosporin
antibiotic) therapy in the first four days of life showed a
remarkably deviating developmental pattern from the trends
observed in the other nontreated subjects. DGGE analysis
of V3-16S rRNA gene amplicons generated profiles with
an overall low complexity that lacked bands corresponding
to bifidobacteria and other strict anaerobes. In fact, band
sequence analysis and random sequencing of 16S rRNA gene
clone libraries indicated that Enterobacteriaceae were the
most dominant group throughout the entire study period. In
contrast to the findings of the two aforementioned studies,
the SDE fingerprinting data reported by Schwiertz et al.
[101] indicated that the bacterial composition in infants was
not necessarily influenced by antibiotic treatment. In the
latter study, the establishment and succession of the neonatal
microbiota in the first month of life of 29 preterm hospital-
ized infants was monitored, and included seven antibiotic-
treated infants receiving cefotaxime and piperazine during
the first three days followed by vancomycin and amikacin
therapy until inflammation was reduced which ranged up
to 21 days. Overall, DGGE analysis with universal V6–V8-
16S rDNA primers showed relatively stable profiles during
and after antibiotic treatment, although the complexity of
the banding pattern generally appeared to be lower compared
to nontreated infants.
Not suprisingly, it has been shown that the human
adult intestinal microbiota is aﬀected to a diﬀerent degree
during antimicrobial therapy depending on the type and/or
activity spectrum of the therapeutic component [77]. In
the latter study, DGGE analysis of fecal samples from one
patient was performed for 12 months during which diﬀerent
antimicrobials were administered. Visual and numerical
analysis of the V3-16S rRNA gene fingerprints representing
the predominant microbiota remained stable over eight
months in the absence of antimicrobials (Ds of 88–91%) and
were only minimally aﬀected following one week ingestion
of ciprofloxacin (Ds of 73%). In contrast, clindamycin
markedly reduced the microbial complexity (Ds of 11–18%).
However, once clindamycin therapy ceased, recovery of some
intestinal groups was evident within days as indicated by
the increasing similarity indices when compared to the
pattern prior to antibiotic treatment (Ds of 36–44%). In
three other patients, cefazolin (i.e., a cephalosporin with
relatively low activity against intestinal anaerobes) caused
only minimal alteration of V3-16S rRNA gene patterns
(Ds of 81–83%) whereas amoxicillin/clavulanate triggered
marked changes in profile compositions (Ds of 19–42%).
Overall, the relative degree of alterations in the univer-
sal DGGE patterns tended to correspond to the relative
activity spectrum of the antimicrobials against intestinal
anaerobes.
In order to reduce the possible side-eﬀects of antimi-
crobial therapy, probiotics are commonly administered in
combination with antimicrobials during and after the period
of intake [188]. In such combinatorial approaches, the
absence of potentially transferable antibiotic resistance genes
in the administered strain has been recognized as one of
the major safety critera for human probiotics [189]. In
this context, the survival and stability of probiotic strains
during antimicrobial therapy are particularly relevant but
have not been studied into large detail. Upon combined
doxycycline (a tetracycline) and probiotic therapy, Saarela
et al. [190] found that the complexity of V6–V8-16S
rDNA DGGE profiles of fecal microbiota was lower (mean
number of bands, 14–25) compared to those of the (control)
group only taking probiotics (mean number of bands,
25–42). Probiotic strains Lactobacillus acidophilus LaCH-5
and Bifidobacterium animalis subsp. lactis Bb-12 from the
administered commercial preparation Trevis were recovered
from fecal samples, and phenotypically and genotypically
characterized for their tetracycline (Tc) resistance. The Tc-
susceptible strain LaCH-5 remained so during therapy,
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whereas recovered isolates of the Tc-resistant strain Bb-
12 containing the tet(W) resistance gene were not found
to have acquired additional Tc resistance genes. Although
these observations evidence the stability of the probiotic
strains as such, however, the authors did not investigate
the possible eﬀect of introducing a tet(W)-carrying strain
during doxycycline therapy on the dissemination of this gene
throughout the intestinal microbiota.
4. LIMITATIONS AND POTENTIAL PITFALLS
Despite its increasing use in the field of molecular microbial
ecology, it is clear that SDE-based community profiling has a
number of limitations that do not allow indepth analysis of
microbial communities as complex as the human intestinal
tract. Some of these limitations, such as detection level and
taxonomic resolution, can be regarded as potential pitfalls
and should be carefully taken into account during protocol
development and data analysis. In fact, many of these critical
factors are situated along the stages prior to the actual
SDE step such as sampling and sample processing, nucleic
acid extraction and community PCR, and deserve specific
attention when troubleshooting SDE problems.
4.1. PCR bias
As discussed above, the choice of an eﬃcient and repro-
ducible nucleic acid extraction method ensuring optimal cell
lysis and maximal removal of various PCR inhibitors present
in intestinal samples is highly crucial. Likewise, possible
bias introduced during PCR amplification by diﬀerential
or preferential amplification of target genes from complex
communities may prejudice the analysis [191]. As a result,
SDE fingerprint profiles may not entirely reflect the actual
composition of the predominant microbiota in the sample
because of a (partial) lack of amplification of certain
DNA/RNA templates. Nonproportional amplification can
be due to several factors [192] including template and
target sequence properties (e.g., GC-content, presence of
secondary structures and template concentration) [191,
193], eﬃciency of primer binding influenced by primer
preference, annealing temperature and primer mismatches,
and the number of PCR cycles [104, 194]. Furthermore,
it has also been reported that formation of chimeric
and heteroduplex molecules during the amplification pro-
cess [99] may generate a distorted view of the actual
microbial diversity [137]. In this context, Petersen and
Dahllo¨f [195] described a new protocol that makes use
of internal standards during DNA extraction and PCR-
SDE in order to compensate for experimental variability.
This modification allows analyzing the relative abundance
of individual species back to the original sample, thereby
facilitating relative comparative analysis of diversity in
complex microbial communities. Other authors have pro-
posed to incorporate an internal standard during PCR to
compare fragment staining intensities between profiles and
allowing quantitative measurements of fragment intensities
[75].
4.2. Taxonomic resolution of the 16S rRNA gene
Although every functional gene can theoretically be used,
target genes for SDE fingerprinting should preferably (i) be
present in a single copy in the bacterial genome; (ii) contain
conserved regions among the members of the population
to allow rational primer design; and (iii) comprise regions
with suﬃcient sequence variation amongst the members of
the population to produce a fingerprint revealing maximal
diversity. Although the 16S rRNA gene is the prototype target
in SDE applications based on the above criteria, it should
be kept in mind that the possible occurrence of intraspecific
multicopy operon heterogeneity [196] and the lack of a
suﬃcient number of polymorphic regions between closely
related taxa are intrinsic limitations that may aﬀect the
taxonomic resolution and complicate interpretation of SDE
fingerprints. Although mostly not recognized as such, both
phenomena are sources of systematic error in community
fingerprinting analyses [135, 197]. As a result of the multi-
operon eﬀect, a single species may appear as several bands
instead of a single band in SDE profiles thereby leading to an
overestimation of the diversity. For example, Satokari et al.
[99] distinguished three distinct DGGE bands when ana-
lyzing the amplicon from Bifidobacterium adolescentis ATCC
15703T obtained with Bifidobacterium-specific PCR primers
Bif164-f and Bif662-GC-r (Table 2). Further examination
revealed the presence of five rRNA gene clusters in this strain,
including two clusters exhibiting microheterogeneity that
were visualized as two separate bands. The third visualized
band appeared to be a heteroduplex of the former two
fragments. Similar observations were detected with the use
of other group-specific primers targetting the Lactobacillus
group [88] and the Bacteroides fragilis subgroup [64]. On the
other hand, an insuﬃcient number of polymorphic regions
in the target gene may lead to an underestimation of the
diversity because bands of two or more species have identical
positions in the community fingerprint. For example, PCR
primers Lac1 and Lac2 specific for the Lactobacillus group
[88, Table 2] do not allow to distinguish members of the
Lactobacillus casei group as a result of identical V3-16S rRNA
gene sequences. Theoretically, the aforementioned eﬀects
can be reduced by choosing the appropriate V region in
the 16S rRNA gene [131, 198]. Alternatively, single-copy
housekeeping genes characterized by higher substitution
rates such as rpoB [199–202] have recently been used as
targets for microbial community profiling, but still await
implementation in intestinal microbiology. To our knowl-
edge, the use of the transaldolase gene in one study for the
detection of bifidobacterial populations in fecal samples [74]
is the only application in intestinal microbiology using an
alternative target gene.
4.3. Taxonomic resolution of SDE profiles
Several authors have identified cases of comigration in SDE
analysis of amplicons showing clear sequence variation [203–
206]. Even for phylogenetically unrelated strains, it has been
reported that the corresponding amplicons might have a
similar melting behavior resulting in poor electrophoretic
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resolution in SDE [207–209]. The phenomenon of comigra-
tion may also cause problems to retrieve reliable sequence
information from individual band extracts. To some extent,
comigration can be addressed by exploiting a typical
advantage of the SDE technology, that is, the use of more
narrow gradients in order to produce high-resolution SDE
profiles with a particular part of the original profile. This
approach has been referred to as denaturing gradient gel
electrophoresis gel expansion [210, DGGEGE].
Especially for SDE profiles from complex ecosystems
such as the intestinal tract, band sequencing analysis may
prove to be less straightforward as anticipated for several
reasons. First of all, there is the possibility of multiple
sequences being present in a single band due to comigration.
In this case, a cloning step should be introduced prior to
actual sequencing of the fragments. Furthermore, it has
been reported that excised DNA fragments are commonly
contaminated with ssDNA originating from other organisms
present in the sample resulting in genetic contamination of
the sequence profile. Elimination of the ssDNA products
through mung bean or S1 nuclease treatment of the eluted
DNA prior to amplification (and cloning) can increase
the success rate to obtain a pure DNA sequence of the
SDE band target [75, 211]. An alternative but more com-
plex approach to overcome both aforementioned problems
simultaneously involves direct cloning from the original
PCR product followed by screening of individual clones
against the environmental sample. In this context, it should
be kept in mind that the size range of fragments that
can be reliably separated by SDE is limited to 100–600 bp
(optimally 200 bp). Sequence analysis of such relatively
small fragments may impede reliable identification up to
the species level. In addition, in silico and DGGE analysis
have revealed cross-reactivity of V3- and V3–V5-16S rDNA
primers with the human 18S rRNA gene [119]. Especially
in case of biopsies or blood-contaminated fecal samples,
coamplification of nontarget eukaryotic DNAwith 16S rRNA
gene primers may lead to an overestimation of bacterial
biodiversity in SDE analysis when no subsequent analysis of
individual community amplicons by cloning and sequencing
is performed.
Next to their relative electrophoretic position and
sequence composition, also the intensity and sharpness of
SDE bands require special attention. Artifactual double
bands, that is, the situation where each prominent band is
accompanied at close distance by a second, often less intense
band, have been reported in several SDE applications. Janse
et al. [212] suggested that an extension of the final PCR
elongation step can be suﬃcient to prevent the formation
of artifactual second bands. The origin of double bands
in SDE was explained by the authors as the formation
of a secondary product due to prematurely terminated
elongation during each PCR cycle. Extended incubation at
high temperature during final elongation should disrupt
such structures and at the same time allow the Taq DNA
polymerase to synthesize a complete amplicon. Another
observation potentially hampering the resolution of SDE
analysis is linked to the phenomenon of extended fuzzy
bands. The source of this inconsistency is the existence
of multiple melting domains (MMDs) in the amplified
fragments which results in a stepwise increase in retardation
and ultimately leads to the visualization of a wide and
diﬀuse band. Little is known about the distribution of
MMD which is dependent on the target fragment and the
phylogenetic group. This phenomenon has been observed
when using universal 16S rRNA gene primers in SDE analysis
of diﬀerent types of environmental samples including feces
[64], water [204], and soil [213]. Weak, fuzzy bands may
erroneously be considered as background smear leading to
misinterpretation of the profile richness. Curving down or
smiling of bands in lanes near the edges of the gel appears
to be an intrinsic feature of any SDE protocol. Although its
actual cause is not entirely clear, the smiling eﬀect is thought
to result from seeping of urea and/or formamide into the
buﬀer during the run, thereby lowering the concentration
of the denaturing substances at the edges of the gel. This
eﬀect can be avoided by skipping the outer side lanes during
loading and/or by applying silicone grease to the spacers
[214].
4.4. Detection limit
The detection limit of SDE-based methods, that is, the
minimum (relative) concentration or number in which any
given member of a complex bacterial ecosystem needs to
be present in order to be visualized in the corresponding
community fingerprint, was initially estimated to approach
1% of the total population [49]. This estimation was later
substantiated for TGGE analysis of intestinal samples [95],
whereas Vanhoutte et al. [64] reported 106 CFU/g feces
(wet weight) as the detection level that could be reached by
DGGE for predominant members of the fecal microbiota.
In this context, it should be stressed that the detection
limit is a relative value that may strongly depend on
several parameters including the taxonomic complexity of
the ecosystem present in the sample, the eﬃciency of DNA
extraction, the total number of bacteria, and the relative
concentration of each organism in the sample. Human stool
usually contains 1010–1012 CFU/g feces, and it is thus possible
that the detection limit may improve if 1010 CFU/g compared
to 1012 CFU/g is present due to a lower competition among
the constituting DNA templates during PCR amplification.
In general, the potential to detect a specific taxon can be
improved by using group-specific primers that can narrow
the size of the target population. Even when using a genus-
specific primer, however, the template DNA ratio may
still aﬀect the DGGE-based detection of certain species
that are underrepresented in a mixed community sample
[128]. Although poorly studied for SDE-based community
fingerprinting of human microbiota, multiple displacement
amplification (MDA) may provide another strategy to
enhance the detection level especially in biopsy samples
with lower bacterial counts. In MDA, the use of 3′ to 5′
exonuclease resistant random oligonucleotide primers and
bacteriophage Phi29 DNA polymerase will enrich any DNA
target [215], and the resulting template pool can be used for
16S rDNA PCR and subsequent SDE profiling, for example,
using TTGE [216].
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5. CONCLUSIONS AND FUTURE PERSPECTIVES
This review has highlighted the broad application spec-
trum of SDE-based techniques in the field of intestinal
microbiology, ranging from primary assessments of the
bacterial complexity and diversity of intestinal community
structures to the monitoring of compositional changes
at diﬀerent population levels upon dietary or therapeutic
interventions. In more advanced approaches, additional
tools such as band sequence analysis, band position analysis,
and blotting analysis permit further taxonomic exploration
of the microbial communities present in the gut. Overall,
SDE techniques are technically fairly simple, fast, flexible,
and reproducible. Because they allow simultaneous analysis
of multiple samples, SDE-based methods may be highly
suitable in the selection of candidate subjects for human
metagenome studies. Taken together with the ability to
visualize poorly or as yet unculturable bacterial groups, these
features have contributed to the current fame and reputation
of SDE technology.
As is the case with any other methodology, however, also
the SDE approach has a number of intrinsic limitations.
Besides the general biases associated with sampling (includ-
ing sample size), total DNA extraction and PCR amplifi-
cation, also more specific restrictions such as intraspecies
16S rRNA gene operon heterogeneities, limited fragment
length, or fuzzy bands can limit the applicability of SDE.
On the other hand, it is important to always consider the
significance and possible consequences of these drawbacks
in the context of the study because some limitations will
not be equally important when monitoring community
stability compared to when assessing biodiversity. One of
the most important steps in the definition of a new SDE
protocol is the choice of the primer target which can already
prevent several potential drawbacks related with SDE. A
careful selection of the target fragment with regard to
sequence variability and the distribution of multiple melting
domains and a clear focus on the phylum of interest is
conducive to achieve the desired resolution. In addition, also
the SDE technology itself is constantly developing. Dena-
turing high-performance liquid chromatography (DHPLC)
has relatively recently been introduced to detect genetic
variation based on the SDE principle, but employs an
HPLC column instead of a polyacrylamide gel matrix
for amplicon separation [217]. When integrated in fully
automated instruments such as the Transgenomic WAVE
systems (http://www.transgenomic.com/), DHPLC analysis
oﬀers several advantages over conventional SDE analysis
including the lack of gel preparation, the higher throughput,
and the possibility to automatically collect sample fractions
for further (sequence) analysis. DHPLC has been successfully
used to analyze microbial communities with a low [218, 219]
or high [220] complexity. One particular study in the field
of intestinal microbiology revealed that DHPLC provides a
number of technical benefits compared to DGGE but appears
to have the same limitations in taxonomic resolution for
profiling 16S rRNA gene amplicons [97]. Other emerging
technologies such as the combination of isotopically labeled
substrate analysis with RNA-DGGE [221] may oﬀer a
promising prospect for implementation in functional studies
on gut microbiota.
In contemporary intestinal microbiology, SDE-based
methods are rarely used as a single or end-point approach
but are usually combined with culture methods and/or
other molecular methods such as clone libraries, FISH, real-
time PCR, and microarrays in a complementary research
strategy. It is beyond doubt that these polyphasic study
designs should be further pursued and developed to
broaden current insights in the microbial diversity, dynam-
ics, and interactions within the intestinal tract. In this
regard, one of the major challenges ahead lies in the
combined analysis of microbial presence and microbial
activity. As an example of such an integrated approach,
parallel DGGE analysis targetting the 16S rRNA gene as
taxonomic marker and the adenosine-5′-phosphosulfate
reductase subunit A gene as functional gene has been used
to study the succession and diversity of sulfate-reducing
bacteria in the mouse gastrointestinal tract [222]. In this
regard, the wealth of information expected from large-
scale sequencing eﬀorts such as the Human Microbiome
Project (http://www.nihroadmap.nih.gov/hmp/) may open
new avenues for the development of SDE primers targeting
specific functional genes. Considering all upcoming techno-
logical developments, it is expected that SDE community
profiling will maintain and even reinforce its position in the
large spectrum of molecular approaches currently employed
to unravel host-microbe and micromicrobe interactions
within the humanmicrobiome. The successful incorporation
of DGGE profiling in the recently launched concept of
functional metagenomics [223], that is, the transgenomic
characterization of key functional members of the micro-
biome that most influence host metabolism and hence
health, brings forward a first line of evidence in that respect.
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